Search

Meera Natarajan

Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )

Most Active Art Unit
1643
Art Unit(s)
1643
Total Applications
1062
Issued Applications
625
Pending Applications
87
Abandoned Applications
376

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6778602 [patent_doc_number] => 20030049683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Rationally designed antibodies' [patent_app_type] => new [patent_app_number] => 10/006593 [patent_app_country] => US [patent_app_date] => 2001-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 23136 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049683.pdf [firstpage_image] =>[orig_patent_app_number] => 10006593 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/006593
Rationally designed antibodies Dec 4, 2001 Issued
Array ( [id] => 9581693 [patent_doc_number] => 08771694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells' [patent_app_type] => utility [patent_app_number] => 09/988013 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 10757 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09988013 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/988013
Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells Nov 15, 2001 Issued
Array ( [id] => 295767 [patent_doc_number] => 07541034 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-06-02 [patent_title] => 'Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors' [patent_app_type] => utility [patent_app_number] => 09/381497 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 16844 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541034.pdf [firstpage_image] =>[orig_patent_app_number] => 09381497 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/381497
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors Mar 18, 1998 Issued
Menu